Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us ![]()
About
Not Confirmed
Not Confirmed
23-26 March, 2026
Global ChemShowGlobal ChemShow
Not Confirmed
Not Confirmed
19-20 December, 2025
BIO Partnering at JPMBIO Partnering at JPM
Not Confirmed
Not Confirmed
12-15 January, 2026
List your booth number for exhibitions, ask us
CONTACT DETAILS




Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
Industry Trade Show
Not Confirmed
23-26 March, 2026
Global ChemShowGlobal ChemShow
Industry Trade Show
Not Confirmed
19-20 December, 2025
BIO Partnering at JPMBIO Partnering at JPM
Industry Trade Show
Not Confirmed
12-15 January, 2026
Digital content

10 Nov 2025
// FIERCE BIOTECH
https://www.fiercebiotech.com/biotech/busy-ai-driven-iambic-therapeutics-raises-over-100m-oversubscribed-funding-round

04 Nov 2025
// BUSINESS WIRE
https://www.businesswire.com/news/home/20251104266121/en/Iambic-to-Participate-in-November-Investor-Conferences

21 Oct 2025
// BUSINESSWIRE
https://www.businesswire.com/news/home/20251021091520/en/Iambic-Announces-Research-Collaboration-with-Jazz-Pharmaceuticals-for-IAM1363-and-Zanidatamab-Combination-Cohort-in-HER2-Positive-Breast-Cancer

20 Oct 2025
// BUSINESSWIRE
https://www.businesswire.com/news/home/20251020414237/en/Iambic-Shares-Clinical-Data-from-Ph11B-Study-of-IAM1363-a-Highly-Selective-Type-2-HER2-Inhibitor-Demonstrating-Monotherapy-Activity-in-Heavily-Pretreated-Patients-with-HER2-Alterations-at-the-2025-ESMO-Congress

01 Oct 2025
// BUSINESSWIRE
https://www.businesswire.com/news/home/20251001729712/en/Iambic-Therapeutics-Announces-the-Addition-of-Shalini-Sharp-to-its-Board-of-Directors

03 Sep 2025
// BUSINESSWIRE
https://www.businesswire.com/news/home/20250903621032/en/Iambic-to-Present-New-Pre-Clinical-NSCLC-Data-for-IAM1363-a-Selective-Type-II-Inhibitor-for-HER2-Cancers-at-the-2025-World-Conference-on-Lung-Cancer
ABOUT THIS PAGE